By Therapeutic Area

Lacrimal System (Dacryocystorhinostomy & Nasolacrimal Duct) Market Analysis

Cross-industry research covering Lacrimal System (Dacryocystorhinostomy & Nasolacrimal Duct) across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports

1 Industries

Reports Covering Lacrimal System (Dacryocystorhinostomy & Nasolacrimal Duct)

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

Endoscopic DCR adoption continues to grow relative to external DCR, and adjuvant pharmacology including 5-fluorouracil injection (NCT07154121) is under active clinical investigation for improving patency rates in primary acquired nasolacrimal duct obstruction with small lacrimal sac anatomy.

14%

Market Share

5.8%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments